Item Type | Name |
Concept
|
Male
|
Academic Article
|
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
|
Academic Article
|
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.
|
Academic Article
|
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
|
Academic Article
|
Randomized, controlled trial of telcagepant over four migraine attacks.
|
Academic Article
|
Acetate causes alcohol hangover headache in rats.
|
Academic Article
|
Frovatriptan as preemptive treatment for fasting-induced migraine.
|
Academic Article
|
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.
|
Academic Article
|
Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
|
Academic Article
|
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.
|
Academic Article
|
Migraine and autonomic nervous system function: a population-based, case-control study.
|
Academic Article
|
Tricyclic antidepressant medication, stress management therapy, and their combination in the management of chronic tension-type headache.
|
Academic Article
|
Hemiplegic cluster.
|
Academic Article
|
Olanzapine in the treatment of refractory migraine and chronic daily headache.
|
Academic Article
|
Hemicrania continua responds to cyclooxygenase-2 inhibitors.
|
Academic Article
|
Reliability and validity of the migraine therapy assessment questionnaire.
|
Academic Article
|
The prevalence of migraine in neurologists.
|
Academic Article
|
Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model.
|
Academic Article
|
Topiramate in migraine prevention: results of a large controlled trial.
|
Academic Article
|
Inpatient treatment of headache: an evidence-based assessment.
|
Academic Article
|
Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
|
Academic Article
|
Cardiovascular risk factors associated with migraine.
|
Academic Article
|
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
|
Academic Article
|
Burden of illness and satisfaction with care among patients with headache seen in a primary care setting.
|
Academic Article
|
Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Cervical epidural blood patch for low CSF pressure headaches.
|
Academic Article
|
Can allodynic migraine patients be identified interictally using a questionnaire?
|
Academic Article
|
Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial.
|
Academic Article
|
Hormone-related headache: pathophysiology and treatment.
|
Academic Article
|
Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study.
|
Academic Article
|
Acute migraine treatment: patterns of use and satisfaction in a clinical population.
|
Academic Article
|
The impact of migraine on daily activities: effect of topiramate compared with placebo.
|
Academic Article
|
Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
|
Academic Article
|
Reversible anorgasmia with topiramate therapy for headache: a report of 7 patients.
|
Academic Article
|
Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Impact of topiramate migraine prophylaxis on workplace productivity: results from two US randomized, double-blind, placebo-controlled, multicenter trials.
|
Academic Article
|
Migrainous visual auras: a life history.
|
Academic Article
|
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.
|
Academic Article
|
Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
|
Academic Article
|
Patients' preference for migraine preventive therapy.
|
Academic Article
|
Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
|
Academic Article
|
Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.
|
Academic Article
|
Less is not more: underutilization of headache medications in a university hospital emergency department.
|
Academic Article
|
The impact of topiramate on health-related quality of life indicators in chronic migraine.
|
Academic Article
|
Cutaneous allodynia in the migraine population.
|
Academic Article
|
Episodic migraine associated with postural orthostatic tachycardia syndrome and vasovagal syncope: migraine triggers neuromediated syncope.
|
Academic Article
|
The headache management trial: a randomized study of coordinated care.
|
Academic Article
|
Intravenous lidocaine infusion for the treatment of post-acoustic neuroma resection headache: a case report.
|
Academic Article
|
Recent developments in migraine.
|
Academic Article
|
Intravenous lidocaine in the treatment of refractory headache: a retrospective case series.
|
Academic Article
|
Migraine prophylaxis with botulinum toxin A is associated with perception of headache.
|
Academic Article
|
Headache prophylaxis with BoNTA: patient characteristics.
|
Academic Article
|
Expanding access to triptans: assessment of clinical outcome.
|
Academic Article
|
Is CGRP a marker for chronic migraine?
|
Academic Article
|
Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study.
|
Academic Article
|
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
|
Academic Article
|
Fremanezumab for the Preventive Treatment of Chronic Migraine.
|
Academic Article
|
Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
|
Academic Article
|
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study.
|
Academic Article
|
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
|
Academic Article
|
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study.
|
Academic Article
|
Lidocaine infusions for refractory chronic migraine: a retrospective analysis.
|